$0.54
(Market cap
$2,097 Mln
Revenue (TTM)
$306 Mln
P/E Ratio
85.3
P/B Ratio
5.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
37.32
-
EV/EBITDA
52.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0.5
-
Face value
--
-
Shares outstanding
51,206,614
10 Years Aggregate
CFO
$20.18 Mln
EBITDA
$-106.45 Mln
Net Profit
$-113.66 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vericel (VCEL)
| 12.3 | -12.0 | 21.3 | 11.2 | 7.2 | -5.7 | 33.6 |
|
BSE Sensex
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Vericel (VCEL)
| -34.4 | 53.7 | 35.2 | -33.0 | 27.3 | 77.5 | 0.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vericel (VCEL)
|
40.4 | 2,096.9 | 306.3 | 24.2 | 8.4 | 6.7 | 85.3 | 5.7 |
| 17.7 | 6,109.1 | 3,117.6 | 157.4 | 14.7 | -- | 37.3 | 190.1 | |
| 205.3 | 10,424.8 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 129.6 | |
| 76.7 | 14,974.8 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 113.1 | 12,310.3 | 830.8 | 54.9 | 3.2 | 8.1 | 264.8 | 17.9 | |
| 12.2 | 10,087.6 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 28.8 | 2.5 | |
| 24.1 | 11,971.8 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 283.8 | 5,591.7 | 290.5 | 197.2 | 82.5 | 19.9 | 28.9 | 5.9 | |
| 66.8 | 6,058.9 | 450.9 | 138.6 | 39.1 | 115.6 | 50.1 | 32.1 | |
| 132.5 | 8,865.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 21.5 |
Shareholding Pattern
View DetailsAbout Vericel (VCEL)
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North... America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts. Read more
-
CEO, President & Director
Mr. Dominick C. Colangelo Esq.
-
CEO, President & Director
Mr. Dominick C. Colangelo Esq.
-
Headquarters
Burlington, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Vericel (VCEL)
What is the current share price of Vericel Corporation (VCEL) Today?
The share price of Vericel Corporation (VCEL) is $40.44 (NASDAQ) as of 01-Sep-2026 15:39 EDT. Vericel Corporation (VCEL) has given a return of 7.2% in the last 3 years.
What is the current PB & PE ratio of Vericel Corporation (VCEL)?
The P/E ratio of Vericel Corporation (VCEL) is 85.31 times as on 28-Aug-2026, a 129 premium to its peers’ median range of 37.32 times.
The P/B ratio of Vericel Corporation (VCEL) is 5.70 times as on 28-Aug-2026, a 26 discount to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
113.52 |
5.29 |
2024 |
276.67 |
9.82 |
2023 |
-565.28 |
7.96 |
2022 |
-77.56 |
6.74 |
2021 |
-262.70 |
11.51 |
What is the 52 Week High and Low of Vericel Corporation (VCEL)?
The 52-week high and low of Vericel Corporation (VCEL) are Rs 49.32 and Rs 28.95 as of 02-Sep-2026.
What is the market cap of Vericel Corporation (VCEL)?
Vericel Corporation (VCEL) has a market capitalisation of $ 2,097 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vericel Corporation (VCEL)?
Before investing in Vericel Corporation (VCEL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.